20 filings
6-K
XTXXF
Adastra Holdings Ltd.
6 Dec 23
Condensed Interim Consolidated Financial Statements
12:21pm
6-K
XTXXF
Adastra Holdings Ltd.
18 Aug 23
Condensed Interim Consolidated Financial Statements
1:20pm
6-K
XTXXF
Adastra Holdings Ltd.
31 May 23
Condensed Interim Consolidated Financial Statements
6:00am
6-K
XTXXF
Adastra Holdings Ltd.
4 May 23
Consolidated Financial Statements
1:01pm
6-K
XTXXF
Adastra Holdings Ltd.
4 May 23
Adastra Holdings Reports FY2022 Results; Demonstrating A Second Year of Record Revenue
11:37am
6-K
yum1n
13 Apr 23
Current report (foreign)
5:39pm
6-K
wpxt25dd
20 Mar 23
Current report (foreign)
3:24pm
6-K
yaisovkv9nda448hf35
3 Mar 23
Current report (foreign)
9:57pm
6-K
e004im
23 Feb 23
Adastra Labs Receives Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Dealer's License
4:08pm
6-K
1yytv
15 Feb 23
Current report (foreign)
5:47pm
6-K
kjvbvj1a
15 Feb 23
Adastra Completes Transaction to Terminate Legacy Supply Agreement, Bringing Phyto Extractions Brand 100% In-House
4:54pm
6-K
qp58m xo5h
29 Nov 22
Adastra Signs Option to Terminate Legacy Supply Agreement to Streamline Operations and Maximize Revenue
8:34pm
6-K
yt4dnac77in 09i
1 Sep 22
Adastra Receives Controlled Substances Dealer's License
3:10pm
6-K
xt3x4jqc5b
26 Aug 22
New Product Launches; Outlines Growth Strategy
8:38pm
6-K
blx8r3aey9zju 8d
31 May 22
Condensed Interim Consolidated Financial Statements
12:00am
6-K
3oxqs lw66y
20 May 22
Adastra Holdings Announces New Director
8:17pm
6-K
u1oj4noi70n9ca
6 May 22
Adastra Holdings Announces 2021 Annual Financial Results
6:02am
6-K
kr0gpz ao1h00ben0
3 May 22
Consolidated Financial Statements
10:35am
6-K
xygvia5wl7vz8s21oi
12 Apr 22
Current report (foreign)
4:19pm
6-K
m71w5b31vu ad8kt5eo
4 Apr 22
Adastra Holdings Expands Co-Manufacturing Portfolio and Provides Facility Expansion Update
4:07pm
- Prev
- 1
- Next